Blog - FreeMind Group

Home
About
- Team
- Professional Process
Blog
Webinars
Events
- FreeMind Supported Events
Contact
Search
Menu Menu

NON-DILUTIVE FUNDING BLOG

All 12 /Conferences 0 /News 10 /Opinions 0 /Opportunities 5 /Presentations 0 /Uncategorized 0 /Webinars 4

SBIR/STTR programs will expire if Congress doesn't reauthorize by Sept. 30. Senator Paul blocked reauthorization because of security problems. New provisions added to address security concerns. Bill passed Senate, expected to pass House. SBIR/STTR extended 3 more years. — UPDATE: Congress on Track to Reauthorize the SBIR and STTR Programs
September 21, 2022/by Ayal Ronen

Update Biden 2B Bioeconomy Boost — Update on Biden’s $2-Billion Biotechnology Boost
September 21, 2022/by Ayal Ronen

SBIR/STTR Programs Could Expire September 30. Reauthorization Opposed by Rand Paul. — SBIR/STTR Programs Could Expire Sept. 30
September 14, 2022/by Ayal Ronen

Biden Bioeconomy Boost Worth Billions for Biotech and Biopharma — Biden Establishes National Biotechnology and Biomanufacturing Initiative with Executive Order
September 13, 2022/by Ayal Ronen

How Non-Dilutive Funding Can Extend Runway in BioPharma, Biotech, and Tech Bio — Is Non-Dilutive Funding the Key to Extending Runway in Biopharma and Biotech?
September 12, 2022/by Ayal Ronen

Non-dilutive funding leads to equity investment — How Non-Dilutive Funding Leads to Equity Investment: The Story of Enalare
August 29, 2022/by Ayal Ronen

$7.245 Billion in Funding Opportunities for Cancer Research. Join our webinar to fund out more. — Webinar: $7+ Billion in Cancer Research Funding Opportunities 2022
April 20, 2022/by Ayal Ronen

$7.245 Billion in Funding Opportunities for Cancer Research. Join our webinar to fund out more. — Cancer Research in 2022: More than $7 Billion in Funding Opportunities
April 5, 2022/by Ayal Ronen

Peer Reviewed Cancer Research Program Funding Opportunties 2022 — $130 Million in Funding Opportunities from PRCRP
April 3, 2022/by Ayal Ronen

CDMRP PRCRP Priorities Fiscal Year 2022 — PRCRP Priorities for Fiscal Year 2022
April 3, 2022/by Ayal Ronen

Get the recording and slides from our CDMRP 2022 funding opportunities webinar — CDMRP Funding Opportunities 2022
March 31, 2022/by Ayal Ronen

Research funding opportunities for ALS from CDMRP, and a webinar about how to apply for them — ALS Research Funding Opportunities from CDMRP in 2022
March 27, 2022/by Ayal Ronen

Page 1 of 2012 3 ›»

Search

Recent Posts

BioPharm America, an EBD event, Sept 28-29, Boston (& Virtual)September 11, 2022 - 3:21 pm
BioForward, Sept 27, OxfordSeptember 11, 2022 - 3:04 pm
Biofuture, a Demy-Colton EventAugust 2, 2022 - 2:14 pm
The HealthTech Investment Forum & Biotech in Europe Forum, Sept. 20-22, BaselJuly 20, 2022 - 3:41 pm
Advanced Therapies Europe, Aug. 31-Sept. 1, LondonJuly 14, 2022 - 1:57 am

Categories

Conferences (168)
News (22)
Opinions (42)
Opportunities (17)
Presentations (79)
Uncategorized (31)
Webinars (60)

Followon Twitter Subscribeto RSS Feed

Website Links

Our Team
Events
Success Stories
Terms & Conditions
Privacy Policy

Blog Categories

Conferences (168)
News (22)
Opinions (42)
Opportunities (17)
Presentations (79)
Uncategorized (31)
Webinars (60)

Meet us at an upcoming event

Oct112022
Cell & Gene Meeting on the Mesa
Carlsbad
Oct182022
Therapeutic Area Partnerships | Diabetes
Virtual
Oct182022
RNA Leaders USA Congress
Boston

All Upcoming Events →

Join our Mailing List

Your Email Here*

Δ

* Don't worry, we hate spam as much as you do.

FreeMind Group, LLC 2016 All rights reserved.

LinkedIn
Twitter
Facebook
Youtube

We use cookies to gather web statistics that help us improve our site. We store no personal details.

Cookie and Privacy Settings

How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, you cannot refuse them without impacting how our site functions. You can block or delete them by changing your browser settings and force blocking all cookies on this website.

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Click to enable/disable Google Analytics tracking.

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Click to enable/disable Google Webfonts.

Google Map Settings:

Click to enable/disable Google Maps.

Vimeo and Youtube video embeds:

Click to enable/disable video embeds.

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Accept settings Hide notification only

Check to enable permanent hiding of message bar and refuse all cookies if you do not opt in. We need 2 cookies to store this setting. Otherwise you will be prompted again when opening a new browser window or new a tab.

Click to enable/disable essential site cookies.